APP and early-onset autosomal dominant Alzheimer disease: By targeting AβPP (amyloid-β precursor protein) for degradation, UBE2O potentially reduces amyloid-β plaque formation, suggesting a protective role in Alzheimer’s disease (Figure 3) [47].